| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $3.7M | -97.3% |
| R&D Expense | $26.4M | -14.6% |
| SG&A Expense | $14.5M | -30.9% |
| Operating Income | -$37.1M | -151.1% |
| Pre-tax Income | -$21.1M | -131.5% |
| Income Tax | $151K | +9.4% |
| Net Income | -$21.3M | -131.8% |
| EPS (Basic) | -$0.44 | -131.4% |
| EPS (Diluted) | -$0.44 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $16.1M | -52.9% |
| Short-term Investments | $43.2M | +7.3% |
| Current Assets | $72.2M | -29.3% |
| Total Assets | $90.6M | -29.4% |
| Current Liabilities | $24.1M | +47.8% |
| Total Liabilities | $35.6M | -35.9% |
| Stockholders' Equity | $55.1M | -24.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$24.0M | -139.9% |
| Investing Cash Flow | $6.2M | +117.6% |
| Financing Cash Flow | -$139K | +99.6% |
| -131.7% |